<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/">

	<channel><title><![CDATA[Latest Publisher Reports]]></title><atom:link href="http://www.researchmoz.com/publisher" rel="self" type="application/rss+xml" />
	<link>http://www.researchmoz.com</link>
	<description><![CDATA[Latest Publisher Reports]]></description>
	<lastBuildDate>Wed, 18 Jul 2012 12:20:54 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator><item><title>Cellular Therapy and Cord Blood 2013 Market Report</title><link>http://www.researchmoz.com/cellular-therapy-and-cord-blood-report.html</link><comments>http://www.researchmoz.com/cellular-therapy-and-cord-blood-report.html#comments</comments><pubDate>Mon, 04 Feb 2013 00:00:00 -0700</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/cellular-therapy-and-cord-blood-report.html</guid><description><![CDATA[
This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences. &nbsp;In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space.

We've analyzed clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization. &nbsp;We also present the breakout of clinical trials in the bona fide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated.
 <br><br>Original Post <a href=http://www.researchmoz.com/cellular-therapy-and-cord-blood-report.html>Cellular Therapy and Cord Blood 2013 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[
This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences. &nbsp;In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space.

We've analyzed clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization. &nbsp;We also present the breakout of clinical trials in the bona fide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated.
 <br><br>Original Post <a href=http://www.researchmoz.com/cellular-therapy-and-cord-blood-report.html>Cellular Therapy and Cord Blood 2013 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/cellular-therapy-and-cord-blood-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2013 Market Report</title><link>http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-2013-market-report-report.html</link><comments>http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-2013-market-report-report.html#comments</comments><pubDate>Tue, 01 Jan 2013 00:00:00 -0700</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-2013-market-report-report.html</guid><description><![CDATA[
This is the latest and most up-to-date Market Report from Select Biosciences addressing the CTC and CSCmarkets as they are evolving. &nbsp;In this report, we focus upon technical and business trends in these spaces as they are fast evolving. &nbsp;

CTCs have been shown to have prognostic value in a number of cancer types and therefore there is extensive research and development activity to develop methodologies for CTC enumeration as well as analysis. &nbsp;Furthermore, there is a lot of clinical trial activity in a number of different cancer classes seeking to establish the clinical utility of CTC measurements in various cancer subtypes.

Select Biosciences has performed worldwide market tracking wherein we&rsquo;ve analyzed research trends in the study of CTCs and CSCs. &nbsp;Qualitative and quantitative analysis of product vendors and their market penetrance, markers utilized for the capture/study of CTCs and CSCs as well as cancer classes wherein there is current research ac <br><br>Original Post <a href=http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-2013-market-report-report.html>Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2013 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[
This is the latest and most up-to-date Market Report from Select Biosciences addressing the CTC and CSCmarkets as they are evolving. &nbsp;In this report, we focus upon technical and business trends in these spaces as they are fast evolving. &nbsp;

CTCs have been shown to have prognostic value in a number of cancer types and therefore there is extensive research and development activity to develop methodologies for CTC enumeration as well as analysis. &nbsp;Furthermore, there is a lot of clinical trial activity in a number of different cancer classes seeking to establish the clinical utility of CTC measurements in various cancer subtypes.

Select Biosciences has performed worldwide market tracking wherein we&rsquo;ve analyzed research trends in the study of CTCs and CSCs. &nbsp;Qualitative and quantitative analysis of product vendors and their market penetrance, markers utilized for the capture/study of CTCs and CSCs as well as cancer classes wherein there is current research ac <br><br>Original Post <a href=http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-2013-market-report-report.html>Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2013 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-2013-market-report-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Companion Diagnostics and Personalized Medicine Market Report 2012</title><link>http://www.researchmoz.com/companion-diagnostics-and-personalized-medicine-market-report-2012-report.html</link><comments>http://www.researchmoz.com/companion-diagnostics-and-personalized-medicine-market-report-2012-report.html#comments</comments><pubDate>Wed, 22 Aug 2012 00:00:00 -0600</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/companion-diagnostics-and-personalized-medicine-market-report-2012-report.html</guid><description><![CDATA[
This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace.Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population&mdash;the field of stratified medicine.

Companion Diagnostics has been rapidly expanding over the past 3 years and in this market report we describe the current state of the marketplace from the following perspectives:



All the Prognostic and Predictive Biomarkers with Potential Clinical Utility are described&mdash;a few have already been developed into CDx and we expect growth in this space
Targeted Therapeutics, Associated Biomarkers, Therapeutic Indications, and Testing Mandates are Described
Companion Diagnostics Partnerships and Collaborations from 2009 to 2012 are Presented&mdash;Provides an Up-to-Date State of th <br><br>Original Post <a href=http://www.researchmoz.com/companion-diagnostics-and-personalized-medicine-market-report-2012-report.html>Companion Diagnostics and Personalized Medicine Market Report 2012</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[
This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace.Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population&mdash;the field of stratified medicine.

Companion Diagnostics has been rapidly expanding over the past 3 years and in this market report we describe the current state of the marketplace from the following perspectives:



All the Prognostic and Predictive Biomarkers with Potential Clinical Utility are described&mdash;a few have already been developed into CDx and we expect growth in this space
Targeted Therapeutics, Associated Biomarkers, Therapeutic Indications, and Testing Mandates are Described
Companion Diagnostics Partnerships and Collaborations from 2009 to 2012 are Presented&mdash;Provides an Up-to-Date State of th <br><br>Original Post <a href=http://www.researchmoz.com/companion-diagnostics-and-personalized-medicine-market-report-2012-report.html>Companion Diagnostics and Personalized Medicine Market Report 2012</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/companion-diagnostics-and-personalized-medicine-market-report-2012-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>MicroRNAs and Exosomes Market Report 2012</title><link>http://www.researchmoz.com/micrornas-and-exosomes-market-report-2012-report.html</link><comments>http://www.researchmoz.com/micrornas-and-exosomes-market-report-2012-report.html#comments</comments><pubDate>Thu, 02 Aug 2012 00:00:00 -0600</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/micrornas-and-exosomes-market-report-2012-report.html</guid><description><![CDATA[
This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA and Exosomesmarkets as they are evolving. &nbsp;In this report, we focus upon the microRNA research marketplace from the perspective of the translational opportunities in these spaces. &nbsp;The focus of this field is moving from basic research towards the utility of associations of microRNA expression patterns in disease. &nbsp;In this manner, microRNA signatures may be validated as biomarkers in many disease areas&mdash;cancers, cardiovascular disease, neurological disease, inflammation, and metabolic diseases.&nbsp;



Select Biosciences has performed worldwide market tracking wherein we&rsquo;ve analyzed end-user research trends in the microRNA as well as Exosome markets&mdash;these areas are evolving in parallel given the opportunity in the Circulating Biomarkers space and the utility of microRNAs and mRNAs to be harvested from exosomes and assayed as signatures for disease.  <br><br>Original Post <a href=http://www.researchmoz.com/micrornas-and-exosomes-market-report-2012-report.html>MicroRNAs and Exosomes Market Report 2012</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[
This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA and Exosomesmarkets as they are evolving. &nbsp;In this report, we focus upon the microRNA research marketplace from the perspective of the translational opportunities in these spaces. &nbsp;The focus of this field is moving from basic research towards the utility of associations of microRNA expression patterns in disease. &nbsp;In this manner, microRNA signatures may be validated as biomarkers in many disease areas&mdash;cancers, cardiovascular disease, neurological disease, inflammation, and metabolic diseases.&nbsp;



Select Biosciences has performed worldwide market tracking wherein we&rsquo;ve analyzed end-user research trends in the microRNA as well as Exosome markets&mdash;these areas are evolving in parallel given the opportunity in the Circulating Biomarkers space and the utility of microRNAs and mRNAs to be harvested from exosomes and assayed as signatures for disease.  <br><br>Original Post <a href=http://www.researchmoz.com/micrornas-and-exosomes-market-report-2012-report.html>MicroRNAs and Exosomes Market Report 2012</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/micrornas-and-exosomes-market-report-2012-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012</title><link>http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market-report-2012-report.html</link><comments>http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market-report-2012-report.html#comments</comments><pubDate>Sun, 01 Jan 2012 00:00:00 -0700</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market-report-2012-report.html</guid><description><![CDATA[This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) and cancer stem cells (CSCs) fields.&nbsp; In this report, we focus upon the biology of CTCs and CSCs as well as explore the inter-relationship between these cell types based upon molecular events.&nbsp; Also presented are research trends which are for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastatic mechanismsThis report analyzes the CTCs marketplace from a technical as well as market perspective describing the biology of CTCs, methodologies currently in use for the purification and study of CTCs, as well as the market landscape for CTCs.This report also describes the current state of the CSC marketplace based on data from research, market landscape, and clinical trial anglesThis is the first report in its class providing a technical as well as a market analysis of CTCs and CSCs.&nbsp; <br><br>Original Post <a href=http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market-report-2012-report.html>Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) and cancer stem cells (CSCs) fields.&nbsp; In this report, we focus upon the biology of CTCs and CSCs as well as explore the inter-relationship between these cell types based upon molecular events.&nbsp; Also presented are research trends which are for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastatic mechanismsThis report analyzes the CTCs marketplace from a technical as well as market perspective describing the biology of CTCs, methodologies currently in use for the purification and study of CTCs, as well as the market landscape for CTCs.This report also describes the current state of the CSC marketplace based on data from research, market landscape, and clinical trial anglesThis is the first report in its class providing a technical as well as a market analysis of CTCs and CSCs.&nbsp; <br><br>Original Post <a href=http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market-report-2012-report.html>Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market-report-2012-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>MicroRNA Market Trends 2011</title><link>http://www.researchmoz.com/microrna-market-trends-2011-report.html</link><comments>http://www.researchmoz.com/microrna-market-trends-2011-report.html#comments</comments><pubDate>Fri, 07 Oct 2011 00:00:00 -0600</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/microrna-market-trends-2011-report.html</guid><description><![CDATA[



This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA research space. In this report, we focus upon the microRNA marketplace via primary market research that allows us to identify qualitative and quantitative trends from the bottom-up.

This report analyzes the microRNA marketplace from a market perspective describing the market trends operative in this space, quantitative penetrance of vendors in the microRNA products space [for research on microRNAs], a detailed analysis of publication trends in the microRNA field based on an analysis of more than 20,000 technical publications on microRNAs to identify research trends and &ldquo;hotspots&rdquo; of microRNA research.

Also presented in this report are detailed associations of microRNAs in various
physiological as well as disease states including:



The Various Types of Cancer
Cardiovascular Disease
CNS Disorders
Hepatic Function and Disorders
Diabetes
Stem Cell Biolo <br><br>Original Post <a href=http://www.researchmoz.com/microrna-market-trends-2011-report.html>MicroRNA Market Trends 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[



This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA research space. In this report, we focus upon the microRNA marketplace via primary market research that allows us to identify qualitative and quantitative trends from the bottom-up.

This report analyzes the microRNA marketplace from a market perspective describing the market trends operative in this space, quantitative penetrance of vendors in the microRNA products space [for research on microRNAs], a detailed analysis of publication trends in the microRNA field based on an analysis of more than 20,000 technical publications on microRNAs to identify research trends and &ldquo;hotspots&rdquo; of microRNA research.

Also presented in this report are detailed associations of microRNAs in various
physiological as well as disease states including:



The Various Types of Cancer
Cardiovascular Disease
CNS Disorders
Hepatic Function and Disorders
Diabetes
Stem Cell Biolo <br><br>Original Post <a href=http://www.researchmoz.com/microrna-market-trends-2011-report.html>MicroRNA Market Trends 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/microrna-market-trends-2011-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Circulating Tumor Cells (CTCs)Market Trends 2011</title><link>http://www.researchmoz.com/circulating-tumor-cells-ctcsmarket-trends-2011-report.html</link><comments>http://www.researchmoz.com/circulating-tumor-cells-ctcsmarket-trends-2011-report.html#comments</comments><pubDate>Fri, 01 Jul 2011 00:00:00 -0600</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/circulating-tumor-cells-ctcsmarket-trends-2011-report.html</guid><description><![CDATA[This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) space. In this report, we focus upon the emerging marketplace for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastasis and mechanisms thereof.This report analyzes the CTCs marketplace from a technical as well as market perspective describing the biology of CTCs, methodologies currently in use for the purification and study of CTCs, as well as the market landscape for CTCs. This is the first report in its class providing a technical as well as a market analysis of CTCs. Data in this report includes a primary market survey performed in May 2011 describing the research trends currently in the CTCs space including: 

Surface markers currently used to identify/purify CTCs
Top Cancer Classes where CTCs are being studied
Breakout of the Marketplace vis-&agrave;-vis Technologies/Approaches for  <br><br>Original Post <a href=http://www.researchmoz.com/circulating-tumor-cells-ctcsmarket-trends-2011-report.html>Circulating Tumor Cells (CTCs)Market Trends 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) space. In this report, we focus upon the emerging marketplace for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastasis and mechanisms thereof.This report analyzes the CTCs marketplace from a technical as well as market perspective describing the biology of CTCs, methodologies currently in use for the purification and study of CTCs, as well as the market landscape for CTCs. This is the first report in its class providing a technical as well as a market analysis of CTCs. Data in this report includes a primary market survey performed in May 2011 describing the research trends currently in the CTCs space including: 

Surface markers currently used to identify/purify CTCs
Top Cancer Classes where CTCs are being studied
Breakout of the Marketplace vis-&agrave;-vis Technologies/Approaches for  <br><br>Original Post <a href=http://www.researchmoz.com/circulating-tumor-cells-ctcsmarket-trends-2011-report.html>Circulating Tumor Cells (CTCs)Market Trends 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/circulating-tumor-cells-ctcsmarket-trends-2011-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Emerging Pharmaceutical Markets 2012</title><link>http://www.researchmoz.com/emerging-pharmaceutical-markets-2012-report.html</link><comments>http://www.researchmoz.com/emerging-pharmaceutical-markets-2012-report.html#comments</comments><pubDate>Thu, 30 Jun 2011 00:00:00 -0600</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/emerging-pharmaceutical-markets-2012-report.html</guid><description><![CDATA[The robust growth in the pharmaceutical markets of emerging world economies has outpaced the overall growth of the global pharmaceutical market. The emerging markets are being driven by rapidly growing economies of these countries, increasing per capita income, increasing prevalence of lifestyle diseases due to rapid urbanization, and low-cost factors. Mainly due to strong performance in the emerging pharmaceutical markets, the global pharmaceutical market is expected to reach US$ 1,020 Billion by the end of 2012. This research study provides extensive and coherent information about pharmaceutical markets in emerging countries. It also gives a detailed statistical and analytical review on the demographics, macroeconomic indicators, disease profile, key drivers and restraints of the emerging pharmaceutical markets.

The report covers all the key aspects of the various emerging pharmaceutical markets and has broadly outlined the factors that are affecting the industry. The report also  <br><br>Original Post <a href=http://www.researchmoz.com/emerging-pharmaceutical-markets-2012-report.html>Emerging Pharmaceutical Markets 2012</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[The robust growth in the pharmaceutical markets of emerging world economies has outpaced the overall growth of the global pharmaceutical market. The emerging markets are being driven by rapidly growing economies of these countries, increasing per capita income, increasing prevalence of lifestyle diseases due to rapid urbanization, and low-cost factors. Mainly due to strong performance in the emerging pharmaceutical markets, the global pharmaceutical market is expected to reach US$ 1,020 Billion by the end of 2012. This research study provides extensive and coherent information about pharmaceutical markets in emerging countries. It also gives a detailed statistical and analytical review on the demographics, macroeconomic indicators, disease profile, key drivers and restraints of the emerging pharmaceutical markets.

The report covers all the key aspects of the various emerging pharmaceutical markets and has broadly outlined the factors that are affecting the industry. The report also  <br><br>Original Post <a href=http://www.researchmoz.com/emerging-pharmaceutical-markets-2012-report.html>Emerging Pharmaceutical Markets 2012</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/emerging-pharmaceutical-markets-2012-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Umbilical Cord Blood Banking Market Trends 2011</title><link>http://www.researchmoz.com/umbilical-cord-blood-banking-market-trends-2011-report.html</link><comments>http://www.researchmoz.com/umbilical-cord-blood-banking-market-trends-2011-report.html#comments</comments><pubDate>Wed, 01 Jun 2011 00:00:00 -0600</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/umbilical-cord-blood-banking-market-trends-2011-report.html</guid><description><![CDATA[



This is the latest and most up-to-date Market Report from Select Biosciences addressing cord blood banking marketplace. In this report, we focus upon cord blood banking and provide quantitative market analysis of the space as it relates to the growth of the field, utilization trends of cord blood for different diseases in different countries of the world.

This report analyzes the umbilical cord blood marketplace from a technical as well as market perspective describing the types of transplantation utilizing cord blood, disease classes treated, size of public cord blood banking, associated growth, as well as market drivers and associated qualitative trends.

This data-driven characterization of the cord blood banking market landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development&mdash;all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions dr <br><br>Original Post <a href=http://www.researchmoz.com/umbilical-cord-blood-banking-market-trends-2011-report.html>Umbilical Cord Blood Banking Market Trends 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[



This is the latest and most up-to-date Market Report from Select Biosciences addressing cord blood banking marketplace. In this report, we focus upon cord blood banking and provide quantitative market analysis of the space as it relates to the growth of the field, utilization trends of cord blood for different diseases in different countries of the world.

This report analyzes the umbilical cord blood marketplace from a technical as well as market perspective describing the types of transplantation utilizing cord blood, disease classes treated, size of public cord blood banking, associated growth, as well as market drivers and associated qualitative trends.

This data-driven characterization of the cord blood banking market landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development&mdash;all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions dr <br><br>Original Post <a href=http://www.researchmoz.com/umbilical-cord-blood-banking-market-trends-2011-report.html>Umbilical Cord Blood Banking Market Trends 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/umbilical-cord-blood-banking-market-trends-2011-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Single Cell Omics 2011</title><link>http://www.researchmoz.com/single-cell-omics-2011-report.html</link><comments>http://www.researchmoz.com/single-cell-omics-2011-report.html#comments</comments><pubDate>Sun, 01 May 2011 00:00:00 -0600</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/single-cell-omics-2011-report.html</guid><description><![CDATA[The single cell Omics revolution is the potential transformation of cellular heterogeneity from a source of noise to a source of new, as yet hidden discoveries. No longer will the variability from one cell to the next confound researchers and force them to average results into irrelevance. Researchers may find, in fact, that this variability is critical for cells to respond to and interact with their environments. But even without the complete revolution, single cell Omics offer significant evolutionary advances in fields of biology and medicine that are already based on single cell analysis, such as immunology, neurobiology, stem cell biology, circulating tumor cells and preimplantation genetic diagnosis. Moreover, the ongoing evolution of single cell Omics technologies provides improvements in sensitivity and throughput that will enable researchers to generate more data from smaller numbers of cells, which can be enabling in cases of precious samples. The result of this (r)evolution  <br><br>Original Post <a href=http://www.researchmoz.com/single-cell-omics-2011-report.html>Single Cell Omics 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[The single cell Omics revolution is the potential transformation of cellular heterogeneity from a source of noise to a source of new, as yet hidden discoveries. No longer will the variability from one cell to the next confound researchers and force them to average results into irrelevance. Researchers may find, in fact, that this variability is critical for cells to respond to and interact with their environments. But even without the complete revolution, single cell Omics offer significant evolutionary advances in fields of biology and medicine that are already based on single cell analysis, such as immunology, neurobiology, stem cell biology, circulating tumor cells and preimplantation genetic diagnosis. Moreover, the ongoing evolution of single cell Omics technologies provides improvements in sensitivity and throughput that will enable researchers to generate more data from smaller numbers of cells, which can be enabling in cases of precious samples. The result of this (r)evolution  <br><br>Original Post <a href=http://www.researchmoz.com/single-cell-omics-2011-report.html>Single Cell Omics 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/single-cell-omics-2011-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Adult Stem Cells Market Trends 2011</title><link>http://www.researchmoz.com/adult-stem-cells-market-trends-2011-report.html</link><comments>http://www.researchmoz.com/adult-stem-cells-market-trends-2011-report.html#comments</comments><pubDate>Fri, 14 Jan 2011 00:00:00 -0700</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/adult-stem-cells-market-trends-2011-report.html</guid><description><![CDATA[This is the latest and most up-to-date Market Report from Select Biosciences addressing the adult stem cells marketplace. In this report, we focus upon adult stem cells (especially mesenchymal stem cells; MSCs) and their properties making them highly suited for the development of cellular therapeutics.

This report details the current status of the cellular therapeutics marketplace, products that are commercialized, market potential, clinical trials pipeline and characterization of this pipeline by therapeutic class. The report also provides an analysis of the cellular therapeutics that are currently performed and categorizes them according to type/class of adult stem cell utilized as well as disease(s) treated.

This report analyzes the umbilical cord blood marketplace from a technical as well as market perspective describing the types of transplantation utilizing cord blood, disease classes treated, size of public cord blood banking, associated growth, as well as market drivers a <br><br>Original Post <a href=http://www.researchmoz.com/adult-stem-cells-market-trends-2011-report.html>Adult Stem Cells Market Trends 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[This is the latest and most up-to-date Market Report from Select Biosciences addressing the adult stem cells marketplace. In this report, we focus upon adult stem cells (especially mesenchymal stem cells; MSCs) and their properties making them highly suited for the development of cellular therapeutics.

This report details the current status of the cellular therapeutics marketplace, products that are commercialized, market potential, clinical trials pipeline and characterization of this pipeline by therapeutic class. The report also provides an analysis of the cellular therapeutics that are currently performed and categorizes them according to type/class of adult stem cell utilized as well as disease(s) treated.

This report analyzes the umbilical cord blood marketplace from a technical as well as market perspective describing the types of transplantation utilizing cord blood, disease classes treated, size of public cord blood banking, associated growth, as well as market drivers a <br><br>Original Post <a href=http://www.researchmoz.com/adult-stem-cells-market-trends-2011-report.html>Adult Stem Cells Market Trends 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/adult-stem-cells-market-trends-2011-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Epigenetics Market Trends 2011</title><link>http://www.researchmoz.com/epigenetics-market-trends-2011-report.html</link><comments>http://www.researchmoz.com/epigenetics-market-trends-2011-report.html#comments</comments><pubDate>Thu, 13 Jan 2011 00:00:00 -0700</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/epigenetics-market-trends-2011-report.html</guid><description><![CDATA[This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented associations of epigenetic modifications with diseases&mdash;especially various types of cancers.This report presents the biological role of various epigenetic modifications in vivo and frames them in the context of specific biological events such as differentiation and disease.This report also examines qualitative and in quantitative terms the research market landscape of epigenetics as it exists currently based on Select Biosciences bottom-up market research on this topic. Presented is market segmentation of epigenetics based on end-user research, based on technology utilization, and based on specific disease areas being studied. The primary market data are derived from a worldwide respondent pool that is highly-representative of the life science research community and <br><br>Original Post <a href=http://www.researchmoz.com/epigenetics-market-trends-2011-report.html>Epigenetics Market Trends 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented associations of epigenetic modifications with diseases&mdash;especially various types of cancers.This report presents the biological role of various epigenetic modifications in vivo and frames them in the context of specific biological events such as differentiation and disease.This report also examines qualitative and in quantitative terms the research market landscape of epigenetics as it exists currently based on Select Biosciences bottom-up market research on this topic. Presented is market segmentation of epigenetics based on end-user research, based on technology utilization, and based on specific disease areas being studied. The primary market data are derived from a worldwide respondent pool that is highly-representative of the life science research community and <br><br>Original Post <a href=http://www.researchmoz.com/epigenetics-market-trends-2011-report.html>Epigenetics Market Trends 2011</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/epigenetics-market-trends-2011-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Cancer Vaccines &amp; Circulating Tumor Cells (CTCs) 2011 Report</title><link>http://www.researchmoz.com/cancer-vaccines-and-circulating-tumor-cells-ctcs-2011-report-report.html</link><comments>http://www.researchmoz.com/cancer-vaccines-and-circulating-tumor-cells-ctcs-2011-report-report.html#comments</comments><pubDate>Mon, 03 Jan 2011 00:00:00 -0700</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/cancer-vaccines-and-circulating-tumor-cells-ctcs-2011-report-report.html</guid><description><![CDATA[This market report from Select Biosciences presents a comprehensive industry analysis of the cancer vaccines space as well as that of the emerging circulating tumor cells (CTCs) space. These two areas are evolving and expanding driven by the greater emphasis on personalized medicine especially in the cancer/oncology space.

Cancer vaccines can be generated using a number of different approaches and this report describes these approaches vis-&agrave;-vis their advantages and disadvantages and associated technical characteristics. Indeed, the FDA-approval of a cancer vaccine for prostate cancer in 2010 was a key milestone in this space and a driver for R&amp;D efforts forward. This report presents the pre-clinical pipeline, early-stage clinical trial pipeline, and the late-stage clinical pipeline for the cancer vaccines space. Also presented are the failed vaccine candidates with a discussion about these failures and how the industry can benefit via a deeper understanding of what compo <br><br>Original Post <a href=http://www.researchmoz.com/cancer-vaccines-and-circulating-tumor-cells-ctcs-2011-report-report.html>Cancer Vaccines &amp; Circulating Tumor Cells (CTCs) 2011 Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[This market report from Select Biosciences presents a comprehensive industry analysis of the cancer vaccines space as well as that of the emerging circulating tumor cells (CTCs) space. These two areas are evolving and expanding driven by the greater emphasis on personalized medicine especially in the cancer/oncology space.

Cancer vaccines can be generated using a number of different approaches and this report describes these approaches vis-&agrave;-vis their advantages and disadvantages and associated technical characteristics. Indeed, the FDA-approval of a cancer vaccine for prostate cancer in 2010 was a key milestone in this space and a driver for R&amp;D efforts forward. This report presents the pre-clinical pipeline, early-stage clinical trial pipeline, and the late-stage clinical pipeline for the cancer vaccines space. Also presented are the failed vaccine candidates with a discussion about these failures and how the industry can benefit via a deeper understanding of what compo <br><br>Original Post <a href=http://www.researchmoz.com/cancer-vaccines-and-circulating-tumor-cells-ctcs-2011-report-report.html>Cancer Vaccines &amp; Circulating Tumor Cells (CTCs) 2011 Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/cancer-vaccines-and-circulating-tumor-cells-ctcs-2011-report-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Multiplexed Diagnostics 2010 Market Report</title><link>http://www.researchmoz.com/multiplexed-diagnostics-2010-market-report-report.html</link><comments>http://www.researchmoz.com/multiplexed-diagnostics-2010-market-report-report.html#comments</comments><pubDate>Sat, 01 May 2010 00:00:00 -0600</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/multiplexed-diagnostics-2010-market-report-report.html</guid><description><![CDATA[
The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points.&nbsp;

Will the FDA finally release the updated IVDMIA guidelines? If so, will the FDA close the CLIA loophole and/or will the FDA require 510(k) approvals for all multivariate diagnostics? Will Genomic Health and Agendia be able to maintain high prices for their flagship tests amidst growing competition? How many new tests will reach the market in 2010? Does the inability of Genomic Health&rsquo;s new colon cancer diagnostic to predict response to chemotherapy indicate ongoing challenges in developing new multivariate diagnostics or is this an isolated example? Will growing competition lead to market confusion? In situations with similar tests, how will physicians and payers decide? Will they want to see more prospective clinical trials? Will prospective clinical trials be more attractive due to the experience of XDx? As mul <br><br>Original Post <a href=http://www.researchmoz.com/multiplexed-diagnostics-2010-market-report-report.html>Multiplexed Diagnostics 2010 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[
The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points.&nbsp;

Will the FDA finally release the updated IVDMIA guidelines? If so, will the FDA close the CLIA loophole and/or will the FDA require 510(k) approvals for all multivariate diagnostics? Will Genomic Health and Agendia be able to maintain high prices for their flagship tests amidst growing competition? How many new tests will reach the market in 2010? Does the inability of Genomic Health&rsquo;s new colon cancer diagnostic to predict response to chemotherapy indicate ongoing challenges in developing new multivariate diagnostics or is this an isolated example? Will growing competition lead to market confusion? In situations with similar tests, how will physicians and payers decide? Will they want to see more prospective clinical trials? Will prospective clinical trials be more attractive due to the experience of XDx? As mul <br><br>Original Post <a href=http://www.researchmoz.com/multiplexed-diagnostics-2010-market-report-report.html>Multiplexed Diagnostics 2010 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/multiplexed-diagnostics-2010-market-report-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine</title><link>http://www.researchmoz.com/stem-cells-market-trends-2010-drug-discoverytoxicity-screening-and-regenerative-medicine-report.html</link><comments>http://www.researchmoz.com/stem-cells-market-trends-2010-drug-discoverytoxicity-screening-and-regenerative-medicine-report.html#comments</comments><pubDate>Thu, 01 Apr 2010 00:00:00 -0600</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/stem-cells-market-trends-2010-drug-discoverytoxicity-screening-and-regenerative-medicine-report.html</guid><description><![CDATA[This market trends report from Select Biosciences presents the results from our latest industry tracking completed in March 2010.&nbsp;The data presented herein are based on primary market surveys from a worldwide respondent pool of industry participants active in the stem cells field. This bottom-up analysis highlights market trends operative and enables the identification of trends vis-a-vis the research marketplace, utilization of different classes of stem cells, as well as the penetrance of different research product vendors into specific segments of the stem cells marketplace.&nbsp;This market report is built using data and analyses from Select Biosciences continual industry tracking of this marketplace and our analysis of this space provides up-to-date qualitative and quantitative market metrics.&nbsp;Specific Topics Covered in this Trends Report:

Primary and Up-to-Date Market Survey from a Worldwide Cross Section of the Stem Cells Industry Participants
Quantitative Market Pe <br><br>Original Post <a href=http://www.researchmoz.com/stem-cells-market-trends-2010-drug-discoverytoxicity-screening-and-regenerative-medicine-report.html>Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[This market trends report from Select Biosciences presents the results from our latest industry tracking completed in March 2010.&nbsp;The data presented herein are based on primary market surveys from a worldwide respondent pool of industry participants active in the stem cells field. This bottom-up analysis highlights market trends operative and enables the identification of trends vis-a-vis the research marketplace, utilization of different classes of stem cells, as well as the penetrance of different research product vendors into specific segments of the stem cells marketplace.&nbsp;This market report is built using data and analyses from Select Biosciences continual industry tracking of this marketplace and our analysis of this space provides up-to-date qualitative and quantitative market metrics.&nbsp;Specific Topics Covered in this Trends Report:

Primary and Up-to-Date Market Survey from a Worldwide Cross Section of the Stem Cells Industry Participants
Quantitative Market Pe <br><br>Original Post <a href=http://www.researchmoz.com/stem-cells-market-trends-2010-drug-discoverytoxicity-screening-and-regenerative-medicine-report.html>Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/stem-cells-market-trends-2010-drug-discoverytoxicity-screening-and-regenerative-medicine-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Adult Stem Cells and iPSCs 2010 Market Report</title><link>http://www.researchmoz.com/adult-stem-cells-and-ipscs-2010-market-report-report.html</link><comments>http://www.researchmoz.com/adult-stem-cells-and-ipscs-2010-market-report-report.html#comments</comments><pubDate>Mon, 01 Mar 2010 00:00:00 -0700</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/adult-stem-cells-and-ipscs-2010-market-report-report.html</guid><description><![CDATA[
This market report from Select Biosciences comprehensively addresses the technology and market landscape governing adult stem cells as well as induced pluripotent stem cells (iPSCs). Adult stem cells currently underlie the majority of cellular therapeutics that are under development worldwide and this market report maps this landscape with particular emphasis on the characteristics of adult stem cells which leverage their utilization for cellular therapy/regenerative medicine.&nbsp;

This market report is built using data and analyses from Select Biosciences continual industry tracking of this marketplace and our deep analysis of this space provides up-to-date qualitative and quantitative market metrics. Primary Market Data Provide a Comprehensive and Bottom-Up Picture of the Space for Adult Stem Cells as wells as for iPSCs.&nbsp;

In this market report, we provide a technical, market (global research trends), intellectual property, and a regulatory map of the iPSC space that is  <br><br>Original Post <a href=http://www.researchmoz.com/adult-stem-cells-and-ipscs-2010-market-report-report.html>Adult Stem Cells and iPSCs 2010 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[
This market report from Select Biosciences comprehensively addresses the technology and market landscape governing adult stem cells as well as induced pluripotent stem cells (iPSCs). Adult stem cells currently underlie the majority of cellular therapeutics that are under development worldwide and this market report maps this landscape with particular emphasis on the characteristics of adult stem cells which leverage their utilization for cellular therapy/regenerative medicine.&nbsp;

This market report is built using data and analyses from Select Biosciences continual industry tracking of this marketplace and our deep analysis of this space provides up-to-date qualitative and quantitative market metrics. Primary Market Data Provide a Comprehensive and Bottom-Up Picture of the Space for Adult Stem Cells as wells as for iPSCs.&nbsp;

In this market report, we provide a technical, market (global research trends), intellectual property, and a regulatory map of the iPSC space that is  <br><br>Original Post <a href=http://www.researchmoz.com/adult-stem-cells-and-ipscs-2010-market-report-report.html>Adult Stem Cells and iPSCs 2010 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/adult-stem-cells-and-ipscs-2010-market-report-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Single Cell Analysis 2010: the New Frontier for &#039;Omics Market Report</title><link>http://www.researchmoz.com/single-cell-analysis-2010-the-new-frontier-for-omics-market-report-report.html</link><comments>http://www.researchmoz.com/single-cell-analysis-2010-the-new-frontier-for-omics-market-report-report.html#comments</comments><pubDate>Fri, 01 Jan 2010 00:00:00 -0700</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/single-cell-analysis-2010-the-new-frontier-for-omics-market-report-report.html</guid><description><![CDATA[

Omics has unleashed a deluge of data that underscores the complexity of biological systems. Simplification and specificity is the new dogma, and one of the most promising approaches is single cell analysis. No longer are large groups of cells containing high and low responders, early and late responders and fast and slow responders averaged into oblivion. Omics technologies are beginning to be used to analyze genes, proteins, and metabolites in single cells, and beginning to meet the significant demand in applications such as cancer biology, stem cell biology, neurobiology, synthetic biology and biofuel and drug development, where understanding and manipulating the full complexity of intracellular pathways is the Holy Grail.&nbsp;

Omics-based single cell analysis is a new market opportunity with potential growth that is almost beyond belief. The market is projected to grow from $70 million in sales in 2009 to more than $575 million in 2015, according to Single Cell Analysis 2010 <br><br>Original Post <a href=http://www.researchmoz.com/single-cell-analysis-2010-the-new-frontier-for-omics-market-report-report.html>Single Cell Analysis 2010: the New Frontier for &#039;Omics Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[

Omics has unleashed a deluge of data that underscores the complexity of biological systems. Simplification and specificity is the new dogma, and one of the most promising approaches is single cell analysis. No longer are large groups of cells containing high and low responders, early and late responders and fast and slow responders averaged into oblivion. Omics technologies are beginning to be used to analyze genes, proteins, and metabolites in single cells, and beginning to meet the significant demand in applications such as cancer biology, stem cell biology, neurobiology, synthetic biology and biofuel and drug development, where understanding and manipulating the full complexity of intracellular pathways is the Holy Grail.&nbsp;

Omics-based single cell analysis is a new market opportunity with potential growth that is almost beyond belief. The market is projected to grow from $70 million in sales in 2009 to more than $575 million in 2015, according to Single Cell Analysis 2010 <br><br>Original Post <a href=http://www.researchmoz.com/single-cell-analysis-2010-the-new-frontier-for-omics-market-report-report.html>Single Cell Analysis 2010: the New Frontier for &#039;Omics Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/single-cell-analysis-2010-the-new-frontier-for-omics-market-report-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>Stem Cells for Cellular Therapy 2010 Market Report</title><link>http://www.researchmoz.com/stem-cells-for-cellular-therapy-2010-market-report-report.html</link><comments>http://www.researchmoz.com/stem-cells-for-cellular-therapy-2010-market-report-report.html#comments</comments><pubDate>Fri, 01 Jan 2010 00:00:00 -0700</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/stem-cells-for-cellular-therapy-2010-market-report-report.html</guid><description><![CDATA[

This is the latest and most up-to-date Market Report from Select Biosciences addressing the cellular therapy space. Select Biosciences&rsquo; industry coverage of the stem cells space is broad and comprehensive-each segment of the space is therefore analyzed and presented in detail in a market report. This market report is focused on presenting the market characteristics of stem cells as they are currently impacting research in the cellular therapy space. Furthermore, this report also addresses an important market, namely that of Umbilical Cord Blood Banking.



Qualitative and Quantitative Trends in the Stem Cells Space: Quantitative Market Forecast (Market Size) by Product Class in the Stem Cells Space and Corresponding Growth Rates
Quantitative Market Forecast (Market Size) by Worldwide Region for Stem Cells Activities and Corresponding Growth Rates
Primary Market Survey Data Derived from a Worldwide Pool of Industry Participants Representing a Broad Cross Section of the S <br><br>Original Post <a href=http://www.researchmoz.com/stem-cells-for-cellular-therapy-2010-market-report-report.html>Stem Cells for Cellular Therapy 2010 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[

This is the latest and most up-to-date Market Report from Select Biosciences addressing the cellular therapy space. Select Biosciences&rsquo; industry coverage of the stem cells space is broad and comprehensive-each segment of the space is therefore analyzed and presented in detail in a market report. This market report is focused on presenting the market characteristics of stem cells as they are currently impacting research in the cellular therapy space. Furthermore, this report also addresses an important market, namely that of Umbilical Cord Blood Banking.



Qualitative and Quantitative Trends in the Stem Cells Space: Quantitative Market Forecast (Market Size) by Product Class in the Stem Cells Space and Corresponding Growth Rates
Quantitative Market Forecast (Market Size) by Worldwide Region for Stem Cells Activities and Corresponding Growth Rates
Primary Market Survey Data Derived from a Worldwide Pool of Industry Participants Representing a Broad Cross Section of the S <br><br>Original Post <a href=http://www.researchmoz.com/stem-cells-for-cellular-therapy-2010-market-report-report.html>Stem Cells for Cellular Therapy 2010 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/stem-cells-for-cellular-therapy-2010-market-report-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item><item><title>MicroRNA Research and Disease Associations 2010 Market Report</title><link>http://www.researchmoz.com/microrna-research-and-disease-associations-2010-market-report-report.html</link><comments>http://www.researchmoz.com/microrna-research-and-disease-associations-2010-market-report-report.html#comments</comments><pubDate>Fri, 01 Jan 2010 00:00:00 -0700</pubDate><dc:creator>admin</dc:creator><guid isPermaLink='false'>http://www.researchmoz.com/microrna-research-and-disease-associations-2010-market-report-report.html</guid><description><![CDATA[This is the latest and most up-to-date Market Report from Select Biosciences addressing MicroRNA Research Market Trends&mdash;both qualitative and quantitative trends including market size, growth rate, and projections. This report contains primary market data characterizing the microRNA research marketplace including market penetrance of different research product vendors into the end-user community, products for microRNA research in the various market segments, research market characteristics&mdash;number of experiments performed, research product pricing, segmentation of the microRNA research market across various research areas, and unmet market needs. Importantly, the key microRNA research market segments where a large opportunity exists are characterized and the penetrance of different technologies in these segments are presented in this market report.An important feature of this market report are the extensive primary market analyses data including primary market survey data fro <br><br>Original Post <a href=http://www.researchmoz.com/microrna-research-and-disease-associations-2010-market-report-report.html>MicroRNA Research and Disease Associations 2010 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></description><content:encoded><![CDATA[This is the latest and most up-to-date Market Report from Select Biosciences addressing MicroRNA Research Market Trends&mdash;both qualitative and quantitative trends including market size, growth rate, and projections. This report contains primary market data characterizing the microRNA research marketplace including market penetrance of different research product vendors into the end-user community, products for microRNA research in the various market segments, research market characteristics&mdash;number of experiments performed, research product pricing, segmentation of the microRNA research market across various research areas, and unmet market needs. Importantly, the key microRNA research market segments where a large opportunity exists are characterized and the penetrance of different technologies in these segments are presented in this market report.An important feature of this market report are the extensive primary market analyses data including primary market survey data fro <br><br>Original Post <a href=http://www.researchmoz.com/microrna-research-and-disease-associations-2010-market-report-report.html>MicroRNA Research and Disease Associations 2010 Market Report</a> <br> source  <a href="http://www.researchmoz.com">Researchmoz</a>]]></content:encoded><wfw:commentRss>http://www.researchmoz.com/microrna-research-and-disease-associations-2010-market-report-report.html/feed</wfw:commentRss><slash:comments>0</slash:comments>	</item></channel></rss>